Unión Europea - español - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios cinfa s.a. - sitagliptina hidrocloruro; metformina hidrocloruro - comprimido recubierto con pelÍcula - 50 mg/1.000 mg - sitagliptina hidrocloruro 50 mg; metformina hidrocloruro 1000 mg - metformina y sitagliptina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios alter s.a. - sitagliptina hidrocloruro monohidrato; metformina hidrocloruro - comprimido recubierto con pelÍcula - 50 mg/1.000 mg - sitagliptina hidrocloruro monohidrato 50 mg; metformina hidrocloruro 1000 mg - metformina y sitagliptina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

teva pharma s.l.u. - sitagliptina hidrocloruro; metformina hidrocloruro - comprimido recubierto con pelÍcula - 50 mg/1.000 mg - sitagliptina hidrocloruro 50 mg; metformina hidrocloruro 1000 mg - metformina y sitagliptina

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - sitagliptin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus, sitagliptin accord is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (ppary) agonist (i. a thiazolidinedione) when use of a ppary agonist is appropriate and when diet and exercise plus the ppary agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a ppary agonist and metformin when use of a ppary agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin accord is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

sandoz farmaceutica s.a. - sitagliptina hidrocloruro monohidrato; metformina hidrocloruro - comprimido recubierto con pelÍcula - 50 mg/1.000 mg - sitagliptina hidrocloruro monohidrato 50 mg; metformina hidrocloruro 1000 mg - metformina y sitagliptina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

kern pharma s.l. - sitagliptina hidrocloruro monohidrato; metformina hidrocloruro - comprimido recubierto con pelÍcula - 50 mg/850 mg - sitagliptina hidrocloruro monohidrato 50 mg; metformina hidrocloruro 850 mg - metformina y sitagliptina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

kern pharma s.l. - sitagliptina hidrocloruro monohidrato; metformina hidrocloruro - comprimido recubierto con pelÍcula - 50 mg/1.000 mg - sitagliptina hidrocloruro monohidrato 50 mg; metformina hidrocloruro 1000 mg - metformina y sitagliptina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorio stada s.l. - sitagliptina hidrocloruro; metformina hidrocloruro - comprimido recubierto con pelÍcula - 50 mg/1.000 mg - sitagliptina hidrocloruro 50 mg; metformina hidrocloruro 1000 mg - metformina y sitagliptina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorios combix s.l.u. - sitagliptina hidrocloruro; metformina hidrocloruro - comprimido recubierto con pelÍcula - 50 mg/1.000 mg - sitagliptina hidrocloruro 50 mg; metformina hidrocloruro 1000 mg - metformina y sitagliptina